Abiopharma

New Form S-8 POS - Mersana Therapeutics, Inc. Filed: 2026-01-06 AccNo: 0001104659-26-001308 Size: 30 KB

Romano Steven J. 🟢 acquired 300.0K shares (1 derivative) of Silence Therapeutics plc (SLN) at $2.05 Transaction Date: Jan 02, 2026 | Filing ID: 000002

Dentsply Sirona to Present at the 44th Annual J.P. Morgan Healthcare Conference

ANI Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

Anaptys to Present at the 44th Annual J.P. Morgan Healthcare Conference

New Form DEF 14A - Twist Bioscience Corp Filed: 2026-01-06 AccNo: 0001581280-26-000006 Size: 7 MB

New Form 424B5 - Praxis Precision Medicines, Inc. Filed: 2026-01-06 AccNo: 0001104659-26-001307 Size: 620 KB

New Form 3 - ELI LILLY & Co Filed: 2026-01-06 AccNo: 0001724605-26-000002 Size: 682 KB

Director Schenkein David P 🟢 acquired 2.1K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $772.76 ($1.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

Integer Holdings Corporation (ITGR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Director GOLDSTEIN JOSEPH L 🟢 acquired 2.1K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $772.76 ($1.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

New Form S-8 POS - Mersana Therapeutics, Inc. Filed: 2026-01-06 AccNo: 0001104659-26-001306 Size: 30 KB

New Form SCHEDULE 13D/A - AVENUE THERAPEUTICS, INC. Filed: 2026-01-06 AccNo: 0001104659-26-001305 Size: 14 KB

Director RYAN ARTHUR F 🟢 acquired 2.1K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $772.76 ($1.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference